Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CRL | ELV | ICLR | AVTR | VTRS |
| Company | Charles River Laboratories Intl | Elevance Health Inc | Icon Plc | Avantor Inc | Viatris Inc |
| Price Information | |||||
| Exchange | NYSE | NYSE | NASDAQ | NYSE | NASDAQ |
| Open | 228.95 | 530.11 | 290.87 | 24.22 | 11.34 |
| High | 232.67 | 536.91 | 299.65 | 24.59 | 11.35 |
| Low | 225.79 | 527.45 | 288.23 | 24.05 | 11.21 |
| Last | 232.56 | 532.22 | 297.93 | 24.41 | 11.25 |
| Change | +5.78 | +0.80 | +9.70 | +0.31 | unch |
| % Change | +2.55% | +0.15% | +3.37% | +1.29% | unch |
| Volume | 544,600 | 1,525,100 | 778,900 | 5,532,700 | 5,099,300 |
| 20-Day Average Volume | 456,335 | 1,151,250 | 462,820 | 4,222,525 | 6,593,160 |
| Previous Close | 226.78 | 531.42 | 288.23 | 24.10 | 11.25 |
| Industry | Medical Services | Medical Services | Medical Services | Medical Services | Medical Services |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 249.88 | 511.49 | 313.34 | 25.11 | 11.60 |
| 20-Day Raw Stochastic | 18.11% | 84.85% | 21.00% | 17.26% | 17.09% |
| 20-Day Relative Strength | 39.32% | 62.94% | 41.82% | 45.91% | 39.74% |
| Weighted Alpha | +20.44 | +18.27 | +46.04 | +25.73 | +17.96 |
| Today's Opinion | 24% Buy | 100% Buy | 40% Buy | 56% Buy | 24% Buy |
| Previous Opinion | 24% Buy | 100% Buy | 24% Buy | 56% Buy | 24% Buy |
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | 100% Buy | 56% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.43% since 04/15/24 | +6.42% since 04/15/24 | -0.40% since 04/15/24 | -1.21% since 04/15/24 | -0.62% since 04/15/24 |
| Low | 223.49 on 04/18/24 | 503.66 on 04/16/24 | 287.02 on 04/19/24 | 24.05 on 04/22/24 | 11.05 on 04/16/24 |
| High | 235.92 on 04/16/24 | 539.11 on 04/18/24 | 301.46 on 04/16/24 | 24.79 on 04/16/24 | 11.35 on 04/22/24 |
| 1-Month | |||||
| %Chg | -14.68% since 03/22/24 | +3.57% since 03/22/24 | -10.26% since 03/22/24 | -6.37% since 03/22/24 | -4.98% since 03/22/24 |
| Low | 223.49 on 04/18/24 | 493.64 on 04/02/24 | 287.02 on 04/19/24 | 24.05 on 04/22/24 | 11.05 on 04/16/24 |
| High | 273.57 on 03/25/24 | 539.11 on 04/18/24 | 338.98 on 04/01/24 | 26.16 on 03/25/24 | 12.22 on 04/03/24 |
| 3-Month | |||||
| %Chg | +7.76% since 01/22/24 | +12.80% since 01/22/24 | +12.33% since 01/22/24 | +11.01% since 01/22/24 | -3.35% since 01/22/24 |
| Low | 211.23 on 01/25/24 | 461.48 on 01/25/24 | 254.60 on 01/31/24 | 21.65 on 01/25/24 | 11.05 on 04/16/24 |
| High | 275.00 on 03/08/24 | 539.11 on 04/18/24 | 344.77 on 03/06/24 | 26.16 on 03/25/24 | 13.62 on 02/23/24 |
| 6-Month | |||||
| %Chg | +25.43% since 10/20/23 | +17.29% since 10/20/23 | +31.41% since 10/20/23 | +18.84% since 10/20/23 | +20.97% since 10/20/23 |
| Low | 161.65 on 11/01/23 | 437.42 on 11/02/23 | 222.32 on 10/24/23 | 16.63 on 10/30/23 | 8.74 on 10/27/23 |
| High | 275.00 on 03/08/24 | 539.11 on 04/18/24 | 344.77 on 03/06/24 | 26.16 on 03/25/24 | 13.62 on 02/23/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,681,665 | 123,661,432 | 23,777,536 | 16,346,572 | 13,496,299 |
| Shares Outstanding, K | 51,511 | 232,700 | 82,495 | 678,281 | 1,199,671 |
| Annual Sales | 4,129,410,000 | 171,340,000,000 | 8,120,180,000 | 6,967,200,000 | 15,426,900,000 |
| Annual Net Income | 474,620,000 | 5,987,000,000 | 612,340,000 | 321,100,000 | 54,700,000 |
| Last Quarter Sales | 1,013,480,000 | 42,647,000,000 | 2,066,250,000 | 1,722,800,000 | 3,837,300,000 |
| Last Quarter Net Income | 187,080,000 | 856,000,000 | 216,420,000 | 98,500,000 | -765,600,000 |
| 60-Month Beta | 1.40 | 0.78 | 1.15 | 1.37 | 1.13 |
| Per-Share Information | |||||
| Most Recent Earnings | 2.46 on 02/14/24 | 10.64 on 04/18/24 | 3.46 on 02/21/24 | 0.25 on 02/14/24 | 0.61 on 02/28/24 |
| Latest Earnings Date | 05/09/24 | 04/18/24 | 04/24/24 | 04/26/24 | 05/09/24 |
| Most Recent Dividend | N/A | 1.630 on 03/07/24 | N/A | N/A | 0.120 on 03/08/24 |
| Next Ex-Dividends Date | N/A | 06/10/24 | N/A | N/A | 03/08/24 |
| Ratios | |||||
| Price/Earnings ttm | 21.37 | 15.32 | 23.74 | 22.71 | 3.81 |